In a finding that is raising eyebrows in New York’s medical circles, NYU Langone researchers say they discovered tiny fragments of plastic inside nine of the ten prostate tumors they examined. Those tumors contained roughly 2.5 times more plastic than nearby noncancerous prostate tissue. The work comes from a small pilot study based on tissue removed during prostate surgery and was unveiled at a major urology meeting this week. It is being described as the first Western analysis to directly compare plastic levels in cancerous versus benign prostate tissue. Scientists call the results surprising and potentially important for understanding environmental cancer risks, but they are equally clear that the study is early-stage and does not prove that plastics cause cancer.
How the team measured plastic in tissue
According to NYU Langone Health, the research team examined matched tumor and benign samples from 10 men who underwent radical prostatectomy. They first reviewed the tissue visually and with Raman microscopy, then used pyrolysis-gas chromatography-mass spectrometry to quantify plastic polymers. To cut down on stray plastic getting into the samples, the group reports using nonplastic instruments whenever possible and processing tissues in clean rooms. On average, tumor samples contained about 39.8 micrograms of plastic per gram of tissue, compared with about 15.5 micrograms per gram in the adjacent noncancerous prostate, the release states.
What the findings show, and what they do not
Conference coverage notes that microscopy picked up particles roughly 1.2 µm to 40 µm in diameter, and chemical testing identified nylon-6 and polystyrene among the most common polymers present, according to ASCO Post. Lead author Stacy Loeb said, “Our pilot study provides important evidence that microplastic exposure may be a risk factor for prostate cancer,” a possibility the team says must be explored in much larger patient groups. Independent experts, meanwhile, have emphasized that the study does not show cause and effect, urging that the work be replicated before anyone draws broad public health conclusions, a note of caution that has been echoed in wider media coverage.
Method debate and prior evidence
Finding microplastics in human tissue is not a straightforward business, and the methods have sparked plenty of debate. Critics warn that contamination and technical limits can produce misleading positives, according to reporting in The Guardian. Even so, other human studies have already turned up plastic in organs. A 2024 paper in The New England Journal of Medicine reported plastic particles inside carotid artery plaques and found an association with higher rates of heart attack, stroke, or death. That work has fueled interest in inflammation as a possible mechanism if the prostate findings are confirmed. Researchers in this field say they now need standardized lab protocols, multi-center sampling, and far larger studies to sort real biological signals from lab or surgical contamination.
Local angle and next steps
The NYU investigators, based at Perlmutter Cancer Center and Tisch Hospital in Manhattan, say they have secured funding to expand the project and examine more prostate specimens, according to ScienceDaily. Local coverage and the conference abstract note that the pilot work received support from the Department of Defense and that the team is planning larger, controlled studies designed to tease apart true exposure patterns from procedural contamination. The Brooklyn Eagle was among the first to push the findings into broader public view. Clinicians caution that, interesting as the data may be, it is far too early to change prostate cancer screening or treatment strategies based on a single small study.
Bottom line
Prostate cancer is common, with recent national figures indicating about one in eight men will receive a diagnosis over their lifetimes. That kind of prevalence means any plausible environmental risk factor is going to get serious scrutiny from researchers and regulators. For now, the NYU work is a provocative early signal. It shows that microplastics can be detected in prostate tissue and that, in this small group of patients, levels were higher in tumors than in nearby benign tissue. It does not demonstrate that plastics cause prostate cancer, and experts say it should not alter how patients are managed while larger, more definitive studies move forward.
